Canada · Delayed Price · Currency is CAD COSCIENS Biopharma Statistics
Total Valuation
TSX:CSCI has a market cap or net worth of CAD 8.73 million. The enterprise value is 4.01 million.
| Market Cap | 8.73M |
| Enterprise Value | 4.01M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CSCI has 997,219 shares outstanding. The number of shares has increased by 0.67% in one year.
| Current Share Class | 997,219 |
| Shares Outstanding | 997,219 |
| Shares Change (YoY) | +0.67% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | n/a |
| Float | 991,374 |
Valuation Ratios
The trailing PE ratio is 0.94.
| PE Ratio | 0.94 |
| Forward PE | n/a |
| PS Ratio | 0.70 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.43 |
| EV / Sales | 0.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.33, with a Debt / Equity ratio of 0.13.
| Current Ratio | 4.33 |
| Quick Ratio | 3.41 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.52 |
| Interest Coverage | -33.19 |
Financial Efficiency
Return on equity (ROE) is -52.83% and return on invested capital (ROIC) is -52.03%.
| Return on Equity (ROE) | -52.83% |
| Return on Assets (ROA) | -16.72% |
| Return on Invested Capital (ROIC) | -52.03% |
| Return on Capital Employed (ROCE) | -37.36% |
| Weighted Average Cost of Capital (WACC) | 12.55% |
| Revenue Per Employee | 442,513 |
| Profits Per Employee | 332,354 |
| Employee Count | 28 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 3.41 |
Taxes
In the past 12 months, TSX:CSCI has paid 11,361 in taxes.
| Income Tax | 11,361 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.87% in the last 52 weeks. The beta is 1.80, so TSX:CSCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | -19.87% |
| 50-Day Moving Average | 8.22 |
| 200-Day Moving Average | 8.06 |
| Relative Strength Index (RSI) | 60.30 |
| Average Volume (20 Days) | 992 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CSCI had revenue of CAD 12.39 million and earned 9.31 million in profits. Earnings per share was 8.83.
| Revenue | 12.39M |
| Gross Profit | 5.65M |
| Operating Income | -8.81M |
| Pretax Income | -8.22M |
| Net Income | 9.31M |
| EBITDA | -7.40M |
| EBIT | -8.81M |
| Earnings Per Share (EPS) | 8.83 |
Balance Sheet
The company has 7.50 million in cash and 2.78 million in debt, with a net cash position of 4.72 million or 4.73 per share.
| Cash & Cash Equivalents | 7.50M |
| Total Debt | 2.78M |
| Net Cash | 4.72M |
| Net Cash Per Share | 4.73 |
| Equity (Book Value) | 21.08M |
| Book Value Per Share | 19.86 |
| Working Capital | 10.59M |
Cash Flow
In the last 12 months, operating cash flow was -5.29 million and capital expenditures -73,845, giving a free cash flow of -5.36 million.
| Operating Cash Flow | -5.29M |
| Capital Expenditures | -73,845 |
| Depreciation & Amortization | 1.41M |
| Net Borrowing | -341,940 |
| Free Cash Flow | -5.36M |
| FCF Per Share | -5.38 |
Margins
Gross margin is 45.60%, with operating and profit margins of -71.13% and 75.11%.
| Gross Margin | 45.60% |
| Operating Margin | -71.13% |
| Pretax Margin | -66.33% |
| Profit Margin | 75.11% |
| EBITDA Margin | -59.76% |
| EBIT Margin | -71.13% |
| FCF Margin | n/a |
Dividends & Yields
TSX:CSCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.67% |
| Shareholder Yield | -0.67% |
| Earnings Yield | 106.65% |
| FCF Yield | -61.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 7, 2026. It was a reverse split with a ratio of 0.333335.
| Last Split Date | Jul 7, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.333335 |
Scores
TSX:CSCI has an Altman Z-Score of 0.21 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.21 |
| Piotroski F-Score | 3 |